Xtl biopharmaceuticals ltd

Major-Pharmaceuticals

XTLB


5 Badner Street
Ramat Gan , 4365603

Executive/
Director

Price

  • Last Close
  • $ 2.65
    $ +0.44 19.91 %
    Aug 29, 2024
  • 52-Week High/Low
  • $3.33 - $0.78
  • YTD
  • 167.7%

  • Trading Volume
  • 3
  • Market Cap Full
  • $ 1.4B
  • Shares Outstanding
  • 544.9M
    Dec 31, 2022
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 16.2% -26.8% -17% -24.5% 36.4% -5% 9.9% -14.4% 15.7% 183.8%
Q2 -15.2% 12.4% 20.2% 3.2% -13.6% 4% 19.8% -35.9% -28.5% -6.3%
Q3 -18% -18.1% -24.1% 18.2% -25.8% 8% 10.3% -27% 5.2% -
Q4 -11.9% -33.3% -8.4% -23.1% -8.3% 59.5% -37.1% 3.6% 4% -
J F M A M J J A S O N D
2024 -17% 3.5% 230.2% 0.4% - - - - - - - -
2023 1.7% 17.1% -2.9% -13.5% 6.1% -22.1% -14.2% 28.7% -4.8% -13.3% 18.8% -3.9%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    -32%-29%-55%-28%-24%-24%130%-9%-58%-14%168%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.06 - - 0.2 0.8 - 0.1 0.09 -0.17
Q2 0.02 0.04 - - - - -0.22 -0.05 -0.07
Q3 0.04 0.02 0.08 - - - - - -0.04
Q4 0.16 0.12 - - - - - -0.14 -
A 0.3 0.2 0.1 0.2 0.8 0 -0.1 -0.1 -0.28

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2019 2020 2021 2022
Mar 514.2 - - -
Jun - - - -
Sep - - - -
Dec 514.2 514.2 544.9 544.9

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - 1 - - 0.3
Equity multiplier - - - - -